Amundi’s Replimune Group REPL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q4
Sell
-2,513
Closed -$29.5K 2186
2024
Q3
$29.5K Hold
2,513
﹤0.01% 1884
2024
Q2
$20.3K Sell
2,513
-245,567
-99% -$1.71M ﹤0.01% 1847
2024
Q1
$1.73M Buy
248,080
+73,632
+42% +$604K ﹤0.01% 1200
2023
Q4
$1.62M Sell
174,448
-407,640
-70% -$4.73M ﹤0.01% 1247
2023
Q3
$8.87M Buy
582,088
+130,041
+29% +$2.55M ﹤0.01% 857
2023
Q2
$9.91M Buy
452,047
+50,032
+12% +$978K 0.01% 845
2023
Q1
$6.64M Sell
402,015
-19,427
-5% -$462K ﹤0.01% 939
2022
Q4
$11.1M Buy
421,442
+56,281
+15% +$1.17M 0.01% 833
2022
Q3
$6.44M Sell
365,161
-8,952
-2% -$171K ﹤0.01% 920
2022
Q2
$7.57M Buy
374,113
+57,259
+18% +$941K 0.01% 835
2022
Q1
$6.27M Sell
316,854
-21,071
-6% -$398K ﹤0.01% 926
2021
Q4
$7.88M Sell
337,925
-16,592
-5% -$496K 0.01% 901
2021
Q3
$10.5M Buy
354,517
+80,822
+30% +$2.62M 0.01% 835
2021
Q2
$10.5M Buy
+273,695
New +$9.36M 0.01% 832

Other funds holding REPL

Amundi's REPL Position: Q4 2024 in Review

Amundi sold out of Replimune Group (REPL) in Q4 2024, closing a stake of 2,513 shares — an estimated $29.5K sold.

Amundi first reported a position in REPL in Q2 2021 and held it in 14 quarters. The position peaked at $11.1M in Q4 2022. 157 funds tracked by Wall St. Rank hold REPL as of Q4 2024.

  • Amundi reported no remaining Replimune Group position as of Q4 2024 after selling out during the quarter.
  • Amundi sold 2,513 Replimune Group shares in Q4 2024, an estimated $29.5K.
  • Amundi first reported a position in Replimune Group in Q2 2021 and held it in 14 quarters.
  • Amundi's Replimune Group position peaked at $11.1M in Q4 2022.
  • 157 funds tracked by Wall St. Rank held Replimune Group as of Q4 2024.

Based on Amundi's 13F filing for Q4 2024, filed 7 Feb 2025.